Rv0063a Still unknown · low auto-curated

H37Rv Rv0063a · MTBC0 - · 53 aa · 68418–68579 H37Rv (+) · RefSeq YP_009030026.1

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)hypothetical protein
MTBC0 PGAP re-annotation—
Revised (this work)Conserved hypothetical protein; no recognised domain. Function unknown.

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

Annotated on the H37Rv protein: this gene has no 1:1 ancestral MTBC0 anchor (PE/PPE, paralogue, IS element, or otherwise unanchored CDS).

In the literature (TB corpus sweep) no title/abstract mention

No TB publication mentions this locus tag in its title or abstract (sweep of a ~330k-abstract PubMed TB corpus). A full-text search does however find 1 candidate paper(s) whose full text is not open access and could not be read here, so this page does not claim that the gene was never studied: the mention may be incidental or substantive. The gene remains dark on function.

Second-source check (tbmonitor): 0 paper(s) against 0 for the PubMed sweep — no mention in either source.

Second-source check (P43.6): tbmonitor finds 0 paper(s) naming this locus tag, the PubMed sweep 0 — no mention in either source. Neither source is complete: across the 210 fiches whose source verdict is dark, 3 are seen only by tbmonitor and 4 only by PubMed, which is why a 'no mention in the literature' statement is never made on a single source here. (The site's own counter reports 209: Rv2438A carries a curated function and is recalled to family_assigned at ingest by the verdict/function coherence guard, so it leaves the dark tally without leaving this cross-check.) A count above zero says the gene has been NAMED in a paper, not that its molecular function is known: Rv2660c carries 38 papers as the latency antigen of the multistage vaccine H56 (Ag85B + ESAT-6 + Rv2660c, Aagaard et al., Nat Med 2011, PMID 21258338) and is still dark on function. Counts are shown side by side and never merged.

Scope of the sweep: What was actually swept: the H37Rv locus tag and the ortholog locus tags (M. bovis Mb…, M. marinum MMAR_…, M. smegmatis MSMEG_…, M. leprae ML…, M. abscessus MAB_…), plus the gene name where one exists. NOT swept: protein and enzyme names, including family shorthands such as Ldt(Mt4) or VapC28, and their orthographic variants. An absent locus-tag mention is therefore evidence about the TAG, and only indirect evidence about the protein (P18.14).

An antigen status or a virulence phenotype is NOT a molecular function: the verdict stays unchanged. This layer adds the missing context, it does not requalify the gene. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole), MULTI-ALIAS sweep of title+abstract: the H37Rv locus tag AND every ortholog identifier (M. bovis Mb…, M. marinum MMAR_…, M. smegmatis MSMEG_…, M. leprae ML…, M. abscessus MAB_…), each hit VERIFIED against the abstract text (word-boundary regex). phase73, 2026-07-13.

Intrinsic disorder (sequence + structure) dark by construction (IDR-orphan)

Predicted disorder72% of residues (metapredict)
Disordered regions1 IDR(s), longest 53 aa [0-53]

both sequence (metapredict) and structure (low AlphaFold pLDDT) indicate little stable globular structure: this gene is dark BY CONSTRUCTION — there is no confident fold for structure/homology search to match, so its obscurity is expected, not a pipeline failure

A property (biophysics), not a function. No LLPS/condensate claim is made from disorder alone. Verdict unchanged. Source: metapredict v3 (Emenecker/Holehouse) per-residue disorder + AlphaFold mean pLDDT (annotation_mtbc P16.13).

Why this gene is still unknown (classification, not failure) MICRO-ORF

The detectors cannot speak here. WALL OF MEASURABILITY. Below ~65 aa a protein cannot carry a full Pfam-A domain, profile-profile search has too little sequence to build a deep profile, and a TM-score around 0.6 against any small fold is ordinary rather than significant. Pocket detection is blind too: on PROVEN enzymes, only 1 of 26 under 200 aa reaches the P2Rank confidence threshold. The absence of a functional call here measures the detectors, not the protein.

Detector state length 53 aa · Pfam domain: none · confident AlphaFold model: no · significant structural hits: 0 · pocket detection: blind (protein below the detector's power) · MS: not detected
Existence vs functionNot MS-detected: neither existence nor function is settled here. A proteomics negative is weak evidence for short, hydrophobic or low-abundance proteins.
What would settle itBench, or a detector built for short proteins. Existence is often provable (MS); function is not inferable in silico with today's tools.

Read with care. A statement about what can be MEASURED on this gene today, not a claim that it has no function, and revisable: a gene enters or leaves this class as the layers change. It stays counted among the dark. phase117_hard_residue.py (P8-résidu-dur), 2026-08-10.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.785 · quasi-invariant (3 sites), pN/pS underpowered
Polymorphic sites (≥ 0.1% of strains) 1 synonymous, 2 missense, 0 nonsense, 1 frameshift
Disruption 1 distinct premature-stop/frameshift site(s); most common in 0.16% of strains (227) · clonal

Read the disruption percentage against its ceiling, not against 100%. The strain collection is deeply imbalanced by clade, so a loss fixed in an entire lineage still shows a small overall fraction: a gene disrupted in every L6 strain caps at 0.96% of the collection, in every M. caprae strain at 0.20%, in every M. microti strain at 0.02%. Of the 705 clades in this collection, 689 have a ceiling below 1%. A figure of "0.15% of strains" is therefore uninterpretable on its own — it can be noise or a complete, lineage-defining loss. Use the clade attribution row above, which gives the sub-clade sizes, and never read the percentage alone.

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Lineage-specific relaxation (candidate, one evidence handle) 1 lineage(s)

L4 disrupted in 0.4% of 55 563 L4 strains, vs 0.2% pooled across the whole MTBC (145k strains) · odds ratio 712.39 · FDR q=0.0

Candidate lineage-specific loss-of-function signal: rare/absent in the other well-sampled lineages (<5%) but risen in the listed lineage(s). ONE handle, not a verdict change (P8 two-handle policy) -- the general phenomenon of lineage-specific gene loss reflecting ecotype-specific selective pressure is already established at genome scale (Silva-Pereira et al. 2024); this signal on an individual dark gene needs an independent second handle before any requalification.

Caveat: Sample-size heterogeneity across MTBC lineages (up to 4 orders of magnitude, 16 smaller lineages excluded for n<500); essentiality is NOT resolvable per lineage (TnSeq data is H37Rv-only). For the two smallest adequate lineages (L5 n=630, L6 n=1364) the frequency floor bottoms out at the absolute minimum of 3 carrier strains -- a handful of strains from a SINGLE transmission cluster (clonal outbreak) can pass this floor without representing independent evolutionary origins of the disrupting allele; no phylogenetic correction for clonal sampling was applied. Treat low-count hits in these two lineages with extra caution.

Reference: Silva-Pereira TT, Soler-Camargo NC, Sá Guimarães AM 2024, Microbiology Spectrum, doi:10.1128/spectrum.02289-23

Outgroup conservation (beyond the MTBC) MTBC-specific

Genus-wide presence (~53 non-MTBC Mycobacterium) present in 0/53 (0%) · 0/4 closest MTBAP relatives
absent from ALL 53 non-MTBC Mycobacterium genomes tested (incl. the closest MTBAP relatives) — a candidate MTBC-specific genetic innovation / host-adaptation factor (confirm by synteny; rule out a short/low-complexity ORF and extreme divergence)
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria

short ORF (53 aa) a shallow stratum may reflect homology-detection failure, not true youth
absent from the whole genus and from all outgroups tested — a candidate MTBC-specific innovation (confirm by synteny; rule out detection failure for short/divergent ORFs)

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Proteomics (mass spectrometry) not detected

Not detected in the mass-spectrometry datasets integrated by PaxDb. This is not evidence of absence, and this atlas can say which bias dominates, because it measured it on its own 482 undetected proteins. Size is the main factor: undetected proteins have a median length of 145 aa against 295 aa for detected ones, and 25.3 % of them are shorter than 100 aa against 6.0 %. Predicted localisation matters far less than usually assumed: detection rates are 89.3 % for globular, 84.9 % for transmembrane, 88.0 % for lipoproteins and 77.8 % for signal-peptide proteins — so a short protein is under-sampled whatever its predicted compartment, and hydrophobicity alone is a weak excuse. Condition-specific expression and few tryptic peptides (PE/PPE repeats) add to this.

Predicted localisation (DeepTMHMM + lipobox) signal peptide

Predictionpredicted secreted protein (signal peptide)
DeepTMHMM classSP

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length53 aa
Molecular weight5.5 kDa
Theoretical pI6.54
GRAVY0.309 (hydrophobic)
Aliphatic index112.6
Aromaticity0.0
Instability index63.6 (unstable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

No Pfam-A domain above the gathering threshold (hmmscan --cut_ga scan completed).

HHpred profile-profile (no confident hit): No confident hit (best 70.2%, YxzE putative bacteriocin, E=2.1; all 25 hits are 43-70% with E-values >1). The hits converge thematically — NOT on a single named fold — toward small membrane/secreted peptides (bacteriocins, phage holins, antimicrobial peptides such as Daisho/MafB2-immunity/conotoxin) and T3SS/flagellar export-gate membrane proteins (FliQ, SpaQ), which is consistent with the DeepTMHMM-predicted signal peptide (SP) and the small size (53 aa). Points to a small secreted or membrane-embedded peptide, but no fold is assignable at the confident level. Remains dark; the small-secreted-peptide lean is recorded, not asserted. top hits PF25184 YxzE putative bacteriocin (70.2%, E=2.1), PF14030 DUF4245 (69.4%, E=3.9), PF04971 Phage_holin_2_1 P21 holin (68.3%, E=1.5), PF30068 Daisho antimicrobial peptide (65%, E=1.8), converging small membrane/secreted-peptide + T3SS/flagellar export-gate hits (FliQ, SpaQ, MafB2 immunity, conotoxin, YhcB) all 43-58%, E>1. Remote homology search on the deep UniRef30 profile (MPI Toolkit), run for the residual dark set.

Genomic context (neighbours & predicted operon) operon of 4

Upstream (5' on genome)Rv0063 (+ strand, 55 bp gap)
Downstream (3' on genome)Rv0064 (+ strand, 40 bp gap)
Predicted operon Rv0063a · Rv0064 · vapB1 · vapC1

Neighbours from the H37Rv annotation (+ strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) no multi-gene operon predicted (singleton) — disagrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Functional interaction network (STRING v12)

This gene is absent from the STRING v12 proteome for M. tuberculosis H37Rv, so no interaction evidence could be queried for it at all — which is a statement about STRING's gene set, not about the protein.

Evidence

  • Annotation from H37Rv (no MTBC0 1:1 anchor; H37Rv protein used): hypothetical protein
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq YP_009030026.1)
  • Domains: Pfam-A via hmmscan --cut_ga — none above threshold
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Lineage-specific relaxation: per-lineage disruption fraction vs the pooled MTBC (145k strains), Fisher exact test with FDR correction; general phenomenon established at genome scale by Silva-Pereira et al. 2024 (doi:10.1128/spectrum.02289-23) -- one evidence handle on this atlas's own dark genes, never sufficient alone for a verdict change
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>H37Rv|Rv0063a|
MIMELSVSVIAGLVIALLAAITPAAGERPESRRQALANAAEAGEHPATSPLRR